Verastem Oncology Priced Underwritten Offering Of 30.94M Common Shares At $8.00 Per Share For $247.5M In Gross Proceeds
Share
Why It Matters
Verastem sold a big batch of new stock shares to raise cash. When a company does this, existing owners get diluted, so watch how they spend the money.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.